If a person without a medical license overrode a physician’s treatment plan in a clinic, they would be charged with the unlicensed practice of medicine. When an insurance company does the same thing through prior authorization, it’s called utilization management, and it’s billed as a cost-control measure. The conduct is identical. The labeling is the only thing protecting it.
This isn’t a fringe position; it’s increasingly the position of physician organizations, state medical boards, and a growing list of state legislatures that have started to push back. The legal fiction that prior authorization isn’t medical decision-making is convenient for insurers and indefensible on the facts.
What prior authorization actually does
When your doctor prescribes a medication or orders a procedure, the insurer’s prior authorization process can override that decision. A nurse, a pharmacist, or sometimes an algorithm reviews the request against criteria the insurer wrote, and if the request doesn’t fit, it’s denied. The treating physician, who has examined the patient, has been overruled by someone who has not.
Insurers describe this as a coverage decision rather than a medical one. The distinction is largely semantic. Telling a patient you will not pay for the treatment their doctor recommends, knowing they cannot afford it without coverage, is functionally a decision about what care that patient receives. The patient experiences it as medical denial because, operationally, that’s what it is.
The harm shows up in the data
The American Medical Association’s annual surveys of physicians on prior authorization have produced a remarkably stable picture: roughly a third of physicians report a prior authorization denial leading to a serious adverse event for a patient, including hospitalization or, in a smaller share of cases, death. Physicians and their staff spend tens of hours per week on prior authorization, time stripped from clinical care.
ProPublica’s investigations into specific insurers, including the leaked findings on internal review practices at major carriers, showed reviewers spending seconds per case on decisions affecting expensive treatments. Whatever this is, it isn’t careful medical evaluation. It’s industrial-scale denial designed to leverage the predictable share of patients who give up rather than appeal.
The reform that’s actually moving
The momentum on this issue is bipartisan and unusual. Multiple states have passed gold-card laws that exempt physicians with high prior-authorization approval rates from the process for routine cases. Federal rules now require faster turnarounds on Medicare Advantage authorizations. The killing of UnitedHealthcare’s CEO produced an uncomfortably honest national conversation about the public’s view of denial practices.
The deeper fix would be straightforward: require that any denial of physician-recommended care be made by a licensed physician in the same specialty, with that physician personally accountable under the same standards as the treating doctor. That single change would either eliminate most denials or expose them to malpractice liability. Insurers oppose it for the same reason.
The takeaway
Prior authorization is the practice of medicine, conducted by people who would be prosecuted for doing it in any other setting. Calling it something else doesn’t change what it is, and the regulatory framework is finally beginning to catch up.
Leave a Reply